ANHUI POLY PHARM CO LTD

Overview

ANHUI POLY PHARM CO LTD is an active pharmaceutical ingredient (API) supplier with 15 active FDA Type II Drug Master Files, covering ALLOPURINOL USP; APREMILAST; CRISABOROLE; CYCLOPHOSPHAMIDE USP; GADOBUTROL USP; GADOTERATE MEGLUMINE.

API / Drug Master Files

ANHUI POLY PHARM CO LTD holds 15 active (16 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• IODIDE (INTERMEDIATE)Active2025-07-31
• HYDROLYSATE (INTERMEDIATE)Active2025-07-31
• IOVERSOL USPActive2025-07-30
• SEMAGLUTIDEActive2025-02-28
• ALLOPURINOL USPActive2024-07-29
• SODIUM NITROPRUSSIDE USPActive2024-05-31
• CRISABOROLEActive2023-11-30
• GADOBUTROL USPActive2023-11-30
• TECOVIRIMAT MONOHYDRATEActive2023-09-20
• VORICONAZOLE USPActive2023-09-01
• APREMILASTActive2023-08-15
• GADOTERIDOL USPActive2023-02-09
• CYCLOPHOSPHAMIDE USPActive2022-07-14
• GADOTERATE MEGLUMINEActive2022-05-31
• MAGNESIUM HYDROXIDE USPActive2021-12-16

Showing 15 of 16 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to ANHUI POLY PHARM CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.